Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||
| Net Income | -17,512 | -9,185 | -2,947 |
| Depreciation Amortization | 2,182 | 1,998 | 674 |
| Accounts payable and accrued liabilities | N/A | -602 | -778 |
| Other Working Capital | -1,856 | -2,694 | -2,621 |
| Other Operating Activity | 1,809 | 1,970 | -710 |
| Operating Cash Flow | $-15,377 | $-8,513 | $-6,382 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -132 | N/A | N/A |
| Other Investing Activity | -4,983 | 0 | 0 |
| Investing Cash Flow | $-5,115 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 9,000 | 7,000 |
| Other Financing Activity | 27,577 | 15,877 | 0 |
| Financing Cash Flow | $27,577 | $24,877 | $7,000 |
| Beginning Cash Position | 1,942 | 1,942 | 1,942 |
| End Cash Position | 9,027 | 18,306 | 2,560 |
| Net Cash Flow | $7,085 | $16,364 | $618 |
| Free Cash Flow | |||
| Operating Cash Flow | -15,377 | -8,513 | -6,382 |
| Free Cash Flow | -15,377 | -8,513 | -6,382 |